Rare diseases
Investigational molecules
Locations
Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
GermanyStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
GermanyStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
GermanyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanySARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
GermanyMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
GermanyA Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
GermanyEnhanced dual antiplatelet therapy with clopidogrel and acetylsalicylic acid for secondary prevention in patients with mild ischemic stroke
GermanySafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)
GermanyPhase 2 Study of Safety and Efficacy of PF-08634404 Alone or with Drug Combination in Adults with Early-Stage or Locally Advanced Non-Small Cell Lung Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
